Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 201–300 of 667
Mokaddas, E. M., Burhamah, M. H. A., Khan, Z. U., & Ahmad, S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-292 · Cited by 43
“In a preliminary study, Brian Smith et al. [38] estimated BDG levels in serum samples from 120 non-immunocompromised children (0.5 to 18 year-old) and found higher levels (mean 68 ± 128 pg/ml) than those reported earlier in adult population [25, 35 ].”
BackgroundResultInfluentialTsitsikas, D. A., Morin, A., Araf, S., Murtagh, B., Johnson, G. L., Vinnicombe, S., Ellis, S. M., Suaris, T. D., Wilks, M., Doffman, S. R., et al. (2012) · Medical Mycology · doi:10.3109/13693786.2011.630040 · Cited by 45
1,3‐ß‐D‐glucan concentrations in blood products predict false positive post‐transfusion results
Liss, B., Cornely, O. A., Hoffmann, D., Dimitriou, V., & Wisplinghoff, H. (2016) · Mycoses · doi:10.1111/myc.12432 · Cited by 42
McLawhorn, A. S., Nawabi, D. H., & Ranawat, A. S. (2016) · The Open Orthopaedics Journal · doi:10.2174/1874325001610010615 · Cited by 42
Performance of 1,3‐beta‐D‐glucan in the diagnosis and monitoring of invasive fusariosis
Nucci, M., Barreiros, G., Reis, H. N., Paixão, M. D. N., Akiti, T., & Nouér, S. A. (2019) · Mycoses · doi:10.1111/myc.12918 · Cited by 45
“Duration (days) of neutropenia, median (range) 15 (4-45)”
Playford, E. G., Eggimann, P., & Calandra, T. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283177967 · Cited by 46
Prevention and treatment of invasive fungal diseases in neutropenic patients
Almyroudis, N. G., & Segal, B. H. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32832e074d · Cited by 46
An Italian consensus for invasive candidiasis management (ITALIC)
Scudeller, L., Viscoli, C., Menichetti, F., Bono, V. D., Cristini, F., Tascini, C., Bassetti, M., & Viale, P. (2013) · Infection · doi:10.1007/s15010-013-0558-0 · Cited by 49
“Role of BDG [31, 33, 50, 63–76]:”
BackgroundApproach to the Solid Organ Transplant Patient with Suspected Fungal Infection
Anesi, J. A., & Baddley, J. W. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.001 · Cited by 42
Overview of Invasive Fungal Infections
Tuite, N. L., & Lacey, K. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-257-5_1 · Cited by 66
Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections
Mery, A., Sendid, B., François, N., Cornu, M., Poissy, J., Guerardel, Y., & Poulain, D. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01655-16 · Cited by 41
“In contrast, there is extensive literature on the diagnostic value of fungal polysaccharide detection, including (1,3)- -D-glucan (BDG) (12), present in Candida and Aspergillus cell walls, and mannan (Mnn) or galactomannan (GM), found in Candida and Aspergillus, respectively.”
BackgroundPreemptive antifungal therapy: still a way to go
Maertens, J. A., Deeren, D., Dierickx, D., & Theunissen, K. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3280106854 · Cited by 41
Laín, A., Elguezabal, N., Brena, S., García-Ruiz, J. C., del Palacio, A., Moragues, M. D., & Pontón, J. (2007) · BMC Microbiology · doi:10.1186/1471-2180-7-35 · Cited by 40
“These techniques include the detection of fungal nucleic acid by PCR [3], (1→3) β-D-glucan [4], D-arabinitol [5] and a number of circulating antigens and antibodies [6].”
MethodAn Introduction to the Medically Important Candida Species
Moran, G., Coleman, D., & Sullivan, D. (2014) · Candida and Candidiasis · doi:10.1128/9781555817176.ch2 · Cited by 40
Zaragoza, R., Perman, J., Salavert, M., Viudes, Solé, A., Jarque, I., Cantón, R., Monte‐Boquet, E., & Romá, E. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3994 · Cited by 46
“D -glucan assay can be used in clinical specimens with a high specifi city and positive predictive value for subjects with proven or probable IFI when compared with control subjects (Ostrosky-Zeichner et al 2005).”
Non-cultural methods for the diagnosis of invasive fungal disease
Mikulska, M., Furfaro, E., & Viscoli, C. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.979788 · Cited by 45
“Interestingly, BG sensitivity was similar for different Candida species, with the exception of Candida parapsilosis, for which a lower sensitivity was noted [93,94].”
ResultHistoplasmosis as a cause for a positive Fungitell™ (1→3)-β-D-glucan test
Egan, L., Connolly, P., Wheat, L. J., Fuller, D., Davis, T. E., Knox, K. S., & Hage, C. A. (2008) · Medical Mycology · doi:10.1080/13693780701642235 · Cited by 40
A problem-oriented approach to liver disease in oncology patients
McDonald, G. B., & Frieze, D. A. (2008) · Gut · doi:10.1136/gut.2007.131136 · Cited by 41
Öz, Y., & Kiraz, N. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.10.168 · Cited by 42
Innate Immune and Fungal Model of Alzheimer’s Disease
Parady, B. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180073 · Cited by 40
“immune response facilitating fungal survival [119].”
Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature
Otto, W. R., Pahud, B. A., & Yin, D. E. (2019) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piz007 · Cited by 43
The mycobiota of the human body: a spark can start a prairie fire
Zhang, D., Wang, Y., Shen, S., Hou, Y., Chen, Y., & Wang, T. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1731287 · Cited by 44
“The immunological method is a technique for detecting fungal antigens, mainly components of the fungal cell wall, such as β-d-glucan.(179) Some laboratory researchers used radioimmunoassay to detect fungal mannan, which has diagnostic significance for systemic candidiasis.”
MethodPneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility
Finkelman, M. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.484001 · Cited by 40
Self-citationHammarström, H., Kondori, N., Friman, V., & Wennerås, C. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2302-9 · Cited by 39
“manufacturer was established based on two studies mainly involving non-neutropenic patients [15, 17].”
Nucci, M., & Anaissie, E. J. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.03.001 · Cited by 40
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole
Ader, F., Bienvenu, A.-L., Rammaert, B., & Nseir, S. (2009) · International Journal of COPD · doi:10.2147/copd.s4229 · Cited by 43
Ayats, J., Martín‐Mazuelos, E., Pemán, J., Quindós, G., Sánchez, F., García‐Rodríguez, J., Guarro, J., Guinea, J., Linares, M. J. P., Pontón, J., et al. (2010) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2010.08.005 · Cited by 49
Bloodstream infections in haematology: Risks and new challenges for prevention
Worth, L. J., & Slavin, M. A. (2008) · Blood Reviews · doi:10.1016/j.blre.2008.10.003 · Cited by 41
Invasive candidiasis and candidemia: from current opinions to future perspectives
Rüping, M., Vehreschild, J. J., & Cornely, O. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902911440 · Cited by 46
Mikulska, M., Giacobbe, D. R., Furfaro, E., Mesini, A., Marchese, A. E., Bono, V. D., & Viscoli, C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.05.020 · Cited by 42
Ruhnke, M., & Schwartz, S. (2016) · Therapeutic Advances in Hematology · doi:10.1177/2040620716656381 · Cited by 37
Diagnosis of invasive fungal infections in immunocompromised children
Dornbusch, H. J., Groll, A. H., & Walsh, T. J. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03336.x · Cited by 37
“Among patients on fluconazole prophylaxis, a slightly, but non-significantly, lower sensitivity was observed than in subjects who had proven IFI not receiving antifungal therapy [48].”
BackgroundResultMikołajewska, A., Schwartz, S., & Ruhnke, M. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01961.x · Cited by 36
Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients
Singh, N., Winston, D. J., Limaye, A. P., Pelletier, S., Safdar, N., Morris, M. I., Meneses, K., Busuttil, R. W., Wagener, M. M., & Wheat, L. J. (2015) · Transplantation · doi:10.1097/tp.0000000000000763 · Cited by 36
“The BG detection in the serum has been shown to be a valuable adjunct for the diagnosis of invasive candidiasis in patients with hematologic disorders.(15,18,19) However, limited data exist regarding the utility of BG in organ transplant recipients.”
BackgroundFungal Infections: Their Diagnosis and Treatment in Transplant Recipients
Thiel, D. H. V., George, M., & Moore, C. M. (2012) · International Journal of Hepatology · doi:10.1155/2012/106923 · Cited by 39
“Its usefulness reflects the fact that glucans are a critical compound of the cell wall of most pathologic fungi except for Cryptococcus and zygomycetes [28–33].”
BackgroundUPDATE ON THE LABORATORY DIAGNOSIS OF INVASIVE FUNGAL INFECTIONS
Posteraro, B., Torelli, R., Carolis, E. D., Posteraro, P., & Sanguinetti, M. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.002 · Cited by 39
Laín, A., Moragues, M. D., García‐Ruiz, J. C., Mendoza, J., Camacho, A., del Palacio, A., & Pontón, J. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-06 · Cited by 44
“Detection of fungal DNA by use of PCR (19), (1-3)- -Dglucan (10, 11), cell wall and cytoplasmic circulating antigens (16, 20), and antibodies against different Candida antigens, including mannan, germ tube-specific antigens, and enolase (3, 5, 8, 12–14, 18), have all been investigated for the serodiagnosis of invasive…”
Ader, F. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0132-1 · Cited by 40
“The main limitation of this test is the detection of whole fungal agents, so that complementary tests are needed to define the fungal agent responsible for the disease [56, 57].”
BackgroundAlmyroudis, N. G., Kontoyiannis, D. P., Sepkowitz, K. A., DePauw, B. E., Walsh, T. J., & Segal, B. H. (2006) · Clinical Infectious Diseases · doi:10.1086/508455 · Cited by 35
Tang, X., Hua, Y., Guan, Q., & Yuan, C. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2574-8 · Cited by 41
O’Leary, R., Einav, S., Léone, M., Madách, K., Martin, C., & Martín‐Loeches, I. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.11.020 · Cited by 36
“When pre-emptive therapy is 2 considered, β-D glucan concentration should be ≥ 60 pg/mL or Candida score should be ≥3 3 (52,53).”
BackgroundCandidemia in Burn Patients: Figures and Facts
Pedrosa, A. F., & Rodrigues, A. G. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e3181f2d4fb · Cited by 37
Candidemia in the 21st Century
Chang, A., Neofytos, D., & Horn, D. (2008) · Future Microbiology · doi:10.2217/17460913.3.4.463 · Cited by 43
“com 89% [36].”
Lamoth, F., Nucci, M., Fernández‐Cruz, A., Azoulay, É., Lanternier, F., Bremerich, J., Einsele, H., Johnson, E., Lehrnbecher, T., Mercier, T., et al. (2023) · Medical Mycology · doi:10.1093/mmy/myad061 · Cited by 36
“Fifth, while ongoing antifungal prophylaxis may alter BDG sensitivity, 46 its impact could not be assessed in the present study because these data were lacking in about half of cases and only few of the remaining cases had received anti-mold prophylaxis.”
BackgroundMikulska, M., Furfaro, E., Bono, V. D., Gualandi, F., Lint, M. T. V., Miletich, F., Bacigalupo, A. P., & Viscoli, C. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00513-10 · Cited by 33
“The kinetics of (1,3)- -D-glucan in each of six patients (pt 1 to 6), compared to those on day 0, the day of the first positive blood culture.”
BackgroundMethodInfluentialDiagnostic Performance of 1→3-β-D-Glucan in Neonatal and Pediatric Patients with Candidemia
Montagna, M. T., Coretti, C., Lovero, G., Giglio, O. D., Montagna, O., Laforgia, N., Santoro, N., & Caggiano, G. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12095871 · Cited by 37
Cascio, G. L., Koncan, R., Stringari, G., Russo, A., Azzini, A. M., Ugolini, A., Ligozzi, M., Polati, E., Cornaglia, G., Concia, E., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2239-z · Cited by 35
Fungal Infections in Cancer Patients
Angarone, M. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_4 · Cited by 34
Management of Fungal or Atypical Periprosthetic Joint Infections
Gebauer, M., Frommelt, L., Achan, P., Tim Board, Conway, J. D., Griffin, W. L., Heidari, N., Kerr, G. J., McLaren, A. C., Nelson, S. B., et al. (2013) · The Journal of Arthroplasty · doi:10.1016/j.arth.2013.09.049 · Cited by 32
INVASIVE CANDIDIASIS IN NON-HEMATOLOGICAL PATIENTS.
Mikulska, M., Bassetti, M., Ratto, S., & Viscoli, C. (2011) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2011.007 · Cited by 37
Son, H., Sung, H., Park, S. Y., Kim, T., Lee, H. J., Kim, S., Chong, Y. P., Lee, S., Choi, S., Kim, Y. S., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188860 · Cited by 34
Antifungal prophylaxis with micafungin in patients treated for childhood cancer
Kusuki, S., Hashii, Y., Yoshida, H., Takizawa, S., Sato, E., Tokimasa, S., Ohta, H., & Ozono, K. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.22140 · Cited by 31
Yamaguchi, M., Kurokawa, T., Ishiyama, K., Aoki, G., Ueda, M., Matano, S., Takami, A., Yamazaki, H., Sawazaki, A., Yamauchi, H., et al. (2011) · Annals of Hematology · doi:10.1007/s00277-011-1277-1 · Cited by 33
Conventional or molecular measurement ofAspergillusload
Clemons, K. V., & Stevens, D. A. (2008) · Medical Mycology · doi:10.1080/13693780802213340 · Cited by 31
Khan, Z. U., Ahmad, S., Mokaddas, E. M., Said, T., Nair, M. P., Halim, M., Nampoory, M. R. N., & McGinnis, M. R. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46549-0 · Cited by 31
“In view of these limitations, efforts have been focused on the development and evaluation of non-invasive markers for the specific and early diagnosis of IA (Hope et al., 2005; Ostrosky-Zeichner et al., 2005; Pickering et al., 2005).”
BackgroundGniadek, A., Krzyściak, P., Twarużek, M., & Macura, A. B. (2017) · International Journal of Occupational Medicine and Environmental Health · doi:10.13075/ijomeh.1896.00841 · Cited by 31
Febrile Neutropenia: Evolving Strategies
Ellis, M. E. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1414.035 · Cited by 42
Anidulafungin: a new echinocandin for candidal infections
de la Torre, P., & Reboli, A. C. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.1.45 · Cited by 33
Recent Progress in the Diagnosis of Pathogenic Candida Species in Blood Culture
Phoompoung, P., & Chayakulkeeree, M. (2016) · Mycopathologia · doi:10.1007/s11046-016-0003-x · Cited by 34
Levesque, É., Rizk, F., Noorah, Z., Aït‐Ammar, N., Cordonnier-Jourdin, C., Anbassi, S. E., Bonnal, C., Azoulay, D., Merle, J., & Botterel, F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040862 · Cited by 32
Aspergillosis in the ICU – The new 21st century problem?
Vandewoude, K., Vogelaers, D., & Blot, S. I. (2006) · Medical Mycology · doi:10.1080/13693780600919262 · Cited by 30
INVASIVE ASPERGILLOSIS IN CHILDREN: UPDATE ON CURRENT GUIDELINES
Apsemidou, A., Petridis, N., Vyzantiadis, T., & Tragiannidis, A. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.048 · Cited by 31
Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children
Steinbach, W. J. (2016) · Journal of Fungi · doi:10.3390/jof2010005 · Cited by 38
Agnelli, C., Bouza, E., Martínez‐Jiménez, M. D. C., Navarro, R., Valerio, M., Machado, M., Guinea, J., Sánchez‐Carrillo, C., Alonso, R., & Muñóz, P. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz555 · Cited by 29
Management of Invasive Candidiasis in the Intensive Care Unit
Playford, E. G., Lipman, J., & Sorrell, T. C. (2010) · Drugs · doi:10.2165/10898550-000000000-00000 · Cited by 30
“In particular, the fungal cell walllinked glucose polymer (1-3)-b-D-glucan (BDG) appears promising,([65-70]) although a positive result does not distinguish between Candida spp.”
Coping with Candida Infections
Evans, S. E. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200907-075al · Cited by 32
Development of a Lateral Flow Immunoassay for the Rapid Diagnosis of Invasive Candidiasis
He, Z., Shi, L.-C., Ran, X., Li, W., Wang, X., & Wang, F. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01451 · Cited by 32
“However, false positive results of mannan or BDG-based detection tests have been described in many cases (Adam et al., 2004; Ostrosky-Zeichner et al., 2005; Zandijk et al., 2008).”
BackgroundMethodKinetics of Serum .BETA.-D-Glucan after Pneumocystis Pneumonia Treatment in Patients with AIDS
Koga, M., Koibuchi, T., Kikuchi, T., Nakamura, H., Miura, T., Iwamoto, A., & Fujii, T. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5296 · Cited by 28
“One of the reasons is that the initial validation of β-D-glucan testing in the United States did not include patients with PCP (19).”
Khan, Z. U., Ahmad, S., & Theyyathel, A. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01461.x · Cited by 29
Invasive candidiasis and candidaemia in neonates and children: update on current guidelines
Tragiannidis, A., Tsoulas, C., & Groll, A. H. (2014) · Mycoses · doi:10.1111/myc.12268 · Cited by 40
Ahmad, S., Khan, Z., & Theyyathel, A. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.04.009 · Cited by 28
“A cutoff value of 80 pg/mL was taken as positive for BDG test as mentioned in the instruction sheet provided with the kit and also used by other investigators in clinical studies (Ostrosky-Zeichner et al. 2005; Pickering et al. 2005).”
MethodEarly diagnosis of invasive aspergillosis in infants and children
Roilides, E. (2006) · Medical Mycology · doi:10.1080/13693780600810057 · Cited by 29
New microbiological techniques for the diagnosis of invasive mycoses caused by filamentous fungi
Quindós, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01605.x · Cited by 28
Leather, H. L., & Wingard, J. R. (2006) · Blood Reviews · doi:10.1016/j.blre.2006.03.001 · Cited by 33
Self-citationUse of 1,3-β-D-glucan in invasive fungal diseases in hematology patients
Giacobbe, D. R., Del Bono, V., Viscoli, C., & Mikulska, M. (2017) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1401467 · Cited by 27
New dosing strategies for liposomal amphotericin B in high-risk patients
Ellis, M. E. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01982.x · Cited by 29
“b-D-Glucan detects a wider range of IFIs but is subject to false-positive findings [13,14].”
BackgroundBašková, L., & Buchta, V. (2012) · Folia Microbiologica · doi:10.1007/s12223-012-0152-3 · Cited by 30
“BDG detection in general provides good sensitivity and specificity in the ranges 70–100 % and 75– 90%, respectively, including in neonatal population (Kohno et al. 1993; Odabasi et al. 2004; Ostrosky-Zeichner et al. 2005; Pazos et al. 2005; Couto et al. 2007; Lu et al. 2011; Mackay et al. 2011).”
BackgroundUse of a Serum (1→3)‐β‐ d ‐Glucan Assay for Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia
Cuétara, M. S., Alhambra, A., Cháves, F., Moragues, M. D., Pontón, J., & del Palacio, A. (2008) · Clinical Infectious Diseases · doi:10.1086/592753 · Cited by 27
Pini, P., Bettua, C., Orsi, C. F., Venturelli, C., Faglioni, L., Forghieri, F., Bigliardi, S., Luppi, F., Girardis, M., & Blasi, E. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2211-y · Cited by 27
Lahmer, T., Rasch, S., Schnappauf, C., Beitz, A., Schmid, R. M., & Huber, W. (2016) · Mycopathologia · doi:10.1007/s11046-016-0011-x · Cited by 27
Invasive Candida Infections in the ICU: Diagnosis and Therapy
Hankovszky, P., Társy, D., Öveges, N., & Molnár, Z. (2015) · The Journal of Critical Care Medicine · doi:10.1515/jccm-2015-0025 · Cited by 31
“Subsequent investigations proved that BDG is an early biomarker of fungal infections [37-39] (except for zygomycetes and cryptococcoses which fungi’s cellular walls do not contain BDG).”
BackgroundRare Invasive Fungal Infections: Epidemiology, Diagnosis and Management
Meletiadis, J., & Roilides, E. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0155-9 · Cited by 29
“The 1,3-b-D-glucan test can be used for diagnosing fusariosis [56], whereas aspergillus galactomannan test may be positive in patients with fusariosis [57].”
BackgroundBono, V. D., Mularoni, A., Furfaro, E., Delfino, E., Rosasco, L., Miletich, F., & Viscoli, C. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00276-09 · Cited by 26
“(1,3)- -D-Glucan (BG) is a component of the cell wall of many fungal organisms, and its presence in serum had been shown to be a reliable marker of invasive fungal infection in both clinical (7, 8, 10, 11) and autoptic (6) studies.”
BackgroundDiagnostics and Susceptibility Testing in Aspergillus
Bernal-Martínez, L., Alastruey-Izquierdo, A., & Cuenca-Estrella, M. (2016) · Future Microbiology · doi:10.2217/fmb.15.140 · Cited by 25
Recent Advances in Diagnostic Approaches for Mucormycosis
Safiia, J., Díaz, M., Alshaker, H., Atallah, C. J., Sakr, P., Moshovitis, D. G., Nawlo, A. A., Franceschi, A. E., Liakos, A. D., & Koo, S. (2024) · Journal of Fungi · doi:10.3390/jof10100727 · Cited by 25
“D -glucan and galactomannan are not present in the cell wall of Mucorales, so they cannot be used as a diagnostic adjunct in mucormy-cosis [48,49].”
BackgroundGrossi, P., Gasperina, D. D., Barchiesi, F., Biancofiore, G., Carafiello, G., GASPERI, A. D., Sganga, G., Menichetti, F., Montagna, M. T., Pea, F., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.06.020 · Cited by 26
Fusarium and Other Opportunistic Hyaline Fungi
Zhang, S. X., O'Donnell, K. L., & Sutton, D. A. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch120 · Cited by 34
Management ofCandidainfections in the adult intensive care unit
Cruciani, M., & Serpelloni, G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.2.175 · Cited by 33
“Data from a recent study show that β D -glucan assay had a high sensitivity for all species of Candida , although differences between species have been observed [89] .”
ResultWingard, J. R. (2007) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2006.11.008 · Cited by 25
Self-citationPatterson, T. F. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00258-7 · Cited by 32
Detection of Beta-Glucan Contamination in Nanotechnology-Based Formulations
Neun, B. W., Cedrone, E., Potter, T. M., Crist, R. M., & Dobrovolskaia, M. A. (2020) · Molecules · doi:10.3390/molecules25153367 · Cited by 27
Fisher, B. T., Boge, C. L. K., Xiao, R., Shuster, S., Chin‐Quee, D. S., Allen, J. E., Shaheen, S. K., Hayden, R. T., Suganda, S., Zaoutis, T. E., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab928 · Cited by 26
Clinical utility of fungal screening assays in adults with severe burns
Blyth, D. M., Chung, K. K., Cancio, L. C., King, B. T., & Murray, C. K. (2012) · Burns · doi:10.1016/j.burns.2012.08.009 · Cited by 25
Vázquez, J. A., & Sobel, J. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_11 · Cited by 37
Utilidad de los marcadores biológicos en el diagnóstico de la candidiasis invasora
Pontón, J. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70003-8 · Cited by 38
Invasive candidiasis in the ICU: evidence based and on the edge of evidence
Hollenbach, E. (2008) · Mycoses · doi:10.1111/j.1439-0507.2008.01571.x · Cited by 25
Early Diagnostic Value of Plasma PCT and BG Assay for CRBSI After OLT
Chen, J., Wang, Y., Shen, Z., Zhu, Z., Song, Y., & Han, R. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2010.11.026 · Cited by 24
Infections in Patients with Acute Leukemia
Rolston, K. V. I. (2014) · Springer eBooks · doi:10.1007/978-3-662-44000-1_1 · Cited by 30
“The former appears to be more useful than the latter and may also be a predictor of outcome [ 116 – 120 ].”
BackgroundMartínez, A., Bono, C., Megías, J., Yáñez, A., Gozalbo, D., & Gil, M. L. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00309 · Cited by 22
“…of viable yeasts in the bone marrow of mice infected with a low virulence strain (Yáñez et al., 2011), and it is well known that some fungal PAMPs such as mannan and glucan are present in the blood of patients with systemic candidiasis (LópezRibot et al., 2004; Ostrosky-Zeichner et al., 2005).”
BackgroundPositive (1-3) B-d-Glucan and cross reactivity of fungal assays in coccidioidomycosis
Zangeneh, T. T., Malo, J., Luraschi-Monjagatta, C., Hage, C. A., Wheat, L. J., Strawter, C., Klotz, S. A., & Knox, K. S. (2014) · Medical Mycology · doi:10.1093/mmy/myu077 · Cited by 23
“[1–3] Serological antibody testing for coccidioidomycosis is useful in the endemic regions, but tests provide false negative results in immunosuppressed patients.”
Background
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.